CDCA2 promotes tumorigenesis and induces radioresistance in oesophageal squamous cell carcinoma cells

被引:6
作者
Xu, Bing [1 ]
Chen, Hui [1 ]
Xu, Zhipeng [2 ]
Yao, Xijuan [1 ]
Sun, Xinchen [1 ]
Cheng, Hongyan [3 ]
机构
[1] Nanjing Med Univ, Affiliated Hosp 1, Dept Radiat Oncol, 300 Guangzhou Rd, Nanjing 210029, Jiangsu, Peoples R China
[2] Southeast Univ, Affiliated Zhongda Hosp, Dept Urol, Nanjing 210009, Jiangsu, Peoples R China
[3] Nanjing Med Univ, Affiliated Hosp 1, Dept Synthet Internal Med, 300 Guangzhou Rd, Nanjing 210029, Jiangsu, Peoples R China
基金
中国国家自然科学基金;
关键词
tumorigenesis; radiosensitivity; The Cancer Genome Atlas; DNA repair; gene set enrichment analysis; cell cycle phase; CANCER-CELLS; DNA-REPAIR; CYCLE; SENSITIVITY; EXPRESSION; BIOMARKERS; CHROMATIN; GENES;
D O I
10.3892/mmr.2021.12169
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Cell division cycle-associated 2 (CDCA2) overexpression has been demonstrated to serve a significant role in tumorigenesis in certain types of cancer. Nevertheless, its role in tumour proliferation and radioresistance in oesophageal squamous cell carcinoma (ESCC) remains to be elucidated. Thus, the present study aimed to elucidate these roles. Data were downloaded from The Cancer Genome Atlas (TCGA) to compare the gene expression profiles. The expression of CDCA2 was higher in ESCC tissues compared with normal tissues. Gene set enrichment analysis was performed based on the ESCC cohorts in TCGA database. This demonstrated that higher expression of CDCA2 was significantly associated with the expression of related components of the cell cycle phase transition and G(2)/M phase transition pathways. Collectively, the results revealed that CDCA2 could serve as an underlying target to regulate tumour growth and radioresistance among patients with ESCC.
引用
收藏
页数:10
相关论文
共 34 条
  • [11] Esophageal cancer: The latest on chemoprevention and state of the art therapies
    Le Bras, Gregoire F.
    Farooq, Muhammad H.
    Falk, Gary W.
    Andl, Claudia D.
    [J]. PHARMACOLOGICAL RESEARCH, 2016, 113 : 236 - 244
  • [12] Epidemiology, etiology, and prevention of esophageal squamous cell carcinoma in China
    Liang, He
    Fan, Jin-Hu
    Qiao, You-Lin
    [J]. CANCER BIOLOGY & MEDICINE, 2017, 14 (01) : 33 - 41
  • [13] PARP inhibitor Olaparib increases the sensitization to radiotherapy in FaDu cells
    Liu, Chuan
    Gross, Neil
    Li, Yanshi
    Li, Guojun
    Wang, Zhihai
    Zhong, Shixun
    Li, Yuncheng
    Hu, Guohua
    [J]. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2020, 24 (04) : 2444 - 2450
  • [14] Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method
    Livak, KJ
    Schmittgen, TD
    [J]. METHODS, 2001, 25 (04) : 402 - 408
  • [15] Alterations in DNA Repair Efficiency are Involved in the Radioresistance of Esophageal Adenocarcinoma
    Lynam-Lennon, Niamh
    Reynolds, John V.
    Pidgeon, Graham P.
    Lysaght, Joanne
    Marignol, Laure
    Maher, Stephen G.
    [J]. RADIATION RESEARCH, 2010, 174 (06) : 703 - 711
  • [16] THE MOLECULAR-BASIS FOR CELL-CYCLE DELAYS FOLLOWING IONIZING-RADIATION - A REVIEW
    MAITY, A
    MCKENNA, WG
    MUSCHEL, RJ
    [J]. RADIOTHERAPY AND ONCOLOGY, 1994, 31 (01) : 1 - 13
  • [17] Recent Advances From Basic and Clinical Studies of Esophageal Squamous Cell Carcinoma
    Ohashi, Shinya
    Miyamoto, Shin'ichi
    Kikuchi, Osamu
    Goto, Tomoyuki
    Amanuma, Yusuke
    Muto, Manabu
    [J]. GASTROENTEROLOGY, 2015, 149 (07) : 1700 - 1715
  • [18] Role of cell cycle in mediating sensitivity to radiotherapy
    Pawlik, TM
    Keyomarsi, K
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2004, 59 (04): : 928 - 942
  • [19] Repo-Man Controls a Protein Phosphatase 1-Dependent Threshold for DNA Damage Checkpoint Activation
    Peng, Aimin
    Lewellyn, Andrea L.
    Schiemann, William P.
    Maller, James L.
    [J]. CURRENT BIOLOGY, 2010, 20 (05) : 387 - 396
  • [20] The Extracellular Matrix-Derived Biomarkers for Diagnosis, Prognosis, and Personalized Therapy of Malignant Tumors
    Petersen, Elena V.
    Chudakova, Daria A.
    Skorova, Ekaterina Yu.
    Anikin, Vladimir
    Reshetov, Igor V.
    Mynbaev, Ospan A.
    [J]. FRONTIERS IN ONCOLOGY, 2020, 10